Home » Stocks » Vesper Healthcare Acquisition

Vesper Healthcare Acquisition Corp. (VSPR)

Vesper Healthcare Acquisition currently trades with the ticker symbol VSPRU
Stock Price: $10.11 USD 0.00 (0.00%)
Updated Oct 20, 2020 4:00 PM EDT - Market closed

Stock Price Chart

Key Info

Market Cap 465.06M
Revenue (ttm) n/a
Net Income (ttm) -1,540
Shares Out 50.00M
EPS (ttm) 0.00
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Oct 20, 2020
Last Price $10.11
Previous Close $0.00
Change ($) 0.00
Change (%) 0.00%
Day's Open 10.16
Day's Range 10.11 - 10.18
Day's Volume 23,014
52-Week Range 0.00 - 10.18

More Stats

Market Cap 465.06M
Enterprise Value n/a
Earnings Date (est) n/a
Ex-Dividend Date n/a
Shares Outstanding 50.00M
Float n/a
EPS (basic) n/a
EPS (diluted) 0.00
FCF / Share n/a
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short n/a
Short Ratio n/a
Short % of Float n/a
Beta n/a
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio n/a
PB Ratio n/a
Revenue n/a
Operating Income n/a
Net Income -1,540
Free Cash Flow n/a
Net Cash n/a
Net Cash / Share n/a
Gross Margin n/a
Operating Margin n/a
Profit Margin n/a
FCF Margin n/a
ROA n/a
ROE n/a
ROIC n/a
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (0)

Buy 0
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: n/a

Price Target

$n/a*
*No analysts have provided price targets for this stock.

Financial Performance

Financial Overview

No financial data available for this stock yet.

Company Profile

Company Details

Full Name Vesper Healthcare Acquisition Corp.
Country United States
CEO Brenton L. Saunders

Stock Information

Ticker Symbol VSPR
Stock Exchange NASDAQ
Industry Blank Checks / SPAC
Unique Identifier NASDAQ: VSPR
IPO Date September 30, 2020

Description

Vesper Healthcare Acquisition is a newly incorporated blank check company incorporated in July 2020 as a Delaware corporation whose business purpose is to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. While we may pursue an acquisition opportunity in any industry or sector, we intend to focus on the pharmaceuticals and healthcare sectors with an emphasis on companies in the medical aesthetics, eye care, longevity and wellness categories. Our founders possess a unique combination of executive, strategic, operational, financial and transactional experience in these sectors, and have demonstrated a strong track record of creating significant shareholder value at leading pharmaceutical, healthcare, biotechnology and aesthetics companies.